Resistin, an adipokine with non-generalized actions on sympathetic nerve activity

Frontiers in Physiology

Volumn 6, Issue NOV, 2015, Pages

  Badoer, Emilio ^a   Kosari, Samin ^a   Stebbing, Martin J ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

Brown adipose tissue; Cardiovascular function; Energy metabolism; Leptin; Resistin; Sympathetic nerve activity; Thermogenesis

Indexed keywords

CYTOKINE RECEPTOR; LEPTIN; RESISTIN; RESISTIN RECEPTOR; UNCLASSIFIED DRUG;

CARDIOVASCULAR RISK; COMPARATIVE STUDY; COMPLEX FORMATION; CYTOKINE RESPONSE; DISEASE ASSOCIATION; HEART INNERVATION; HUMAN; HYPERTENSION; MUSCLE SYMPATHETIC NERVE ACTIVITY; NERVE CELL STIMULATION; OBESITY; PATHOGENESIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE;

EID: 84949554482     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00321     Document Type: Review

References (85)

1. Abramson, J. L., Lewis, C., and Murrah, N. V. (2011). Body mass index, leptin, and ambulatory blood pressure variability in healthy adults. Atherosclerosis 214, 456-461. doi: 10.1016/j.atherosclerosis.2010.11.003.
2. Aizawa-Abe, M., Ogawa, Y., Masuzaki, H., Ebihara, K., Satoh, N., Iwai, H., et al. (2000). Pathophysiological role of leptin in obesity-related hypertension. J. Clin. Invest. 105, 1243-1252. doi: 10.1172/JCI8341.
3. Alvarez, G. E., Beske, S. D., Ballard, T. P., and Davy, K. P. (2002). Sympathetic neural activation in visceral obesity. Circulation 106, 2533-2536. doi: 10.1161/01.CIR.0000041244.79165.25.
4. Armitage, J. A., Burke, S. L., Prior, L. J., Barzel, B., Eikelis, N., Lim, K., et al. (2012). Rapid onset of renal sympathetic nerve activation in rabbits fed a high-fat diet. Hypertension 60, 163-171. doi: 10.1161/HYPERTENSIONAHA.111.190413.
5. Asgary, S., SamsamShariat, S. Z., Ghorbani, A., Keshivan, M., Sahebkar, A., and and, N, Sarrafzadegan. (2014). Relationship between serum resistin concentrations with metabolic syndrome and its components in an Iranian population. Diabetes Metab. Syndr. doi: 10.1016/j.dsx.2014.09.007. [Epub ahead of print].
6. Asterholm, I. W., Rutkowski, J. M., Fujikawa, T., Cho, Y. R., Fukuda, M., Tao, C., et al. (2014). Elevated resistin levels induce central leptin resistance and increased atherosclerotic progression in mice. Diabetologia 57, 1209-1218. doi: 10.1007/s00125-014-3210-3.
7. Azuma, K., Katsukawa, F., Oguchi, S., Murata, M., Yamazaki, H., Shimada, A., et al. (2003). Correlation between serum resistin level and adiposity in obese individuals. Obes. Res. 11, 997-1001. doi: 10.1038/oby.2003.137.
8. Badoer, E. (2010). The role of the hypothalamic PVN in the regulation of renal sympathetic nerve activity and blood flow during hyperthermia and in heart failure. Am. J. Physiol. Renal. Physiol. 298, F839-F846. doi: 10.1152/ajprenal.00734.2009.
9. Beltowski, J. (2006). Role of leptin in blood pressure regulation and arterial hypertension. J. Hypertens. 24, 789-801. doi: 10.1097/01.hjh.0000222743.06584.66.
10. Bryzgalova, G., Lundholm, L., Portwood, N., Gustafsson, J. A., Khan, A., Efendic, S., et al. (2008). Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. Am. J. Physiol. Endocrinol. Metab. 295, E904-E912. doi: 10.1152/ajpendo.90248.2008.
11. Coats, A. J., and Cruickshank, J. M. (2014). Hypertensive subjects with type-2 diabetes, the sympathetic nervous system, and treatment implications. Int. J. Cardiol. 174, 702-709. doi: 10.1016/j.ijcard.2014.04.204.
12. Curat, C. A., Wegner, V., Sengenès, C., Miranville, A., Tonus, C., Busse, R., et al. (2006). Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 49, 744-747. doi: 10.1007/s00125-006-0173-z.
13. Daquinag, A. C., Zhang, Y., Amaya-Manzanares, F., Simmons, P. J., and Kolonin, M. G. (2011). An isoform of decorin is a resistin receptor on the surface of adipose progenitor cells. Cell Stem Cell 9, 74-86. doi: 10.1016/j.stem.2011.05.017.
14. da Silva, A. A., Kuo, J. J., and Hall, J. E. (2004). Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin. Hypertension 43, 1312-1317. doi: 10.1161/01.HYP.0000128421.23499.b9.
15. de Luis, D. A., Gonzalez Sagrado, M., Conde, R., Aller, R., Izaola, O., Perez Castrillon, J. L., et al. (2009). Relation of resistin levels with cardiovascular risk factors and insulin resistance in non-diabetes obese patients. Diabetes Res. Clin. Pract. 84, 174-178. doi: 10.1016/j.diabres.2009.01.017.
16. Dimitriadis, K., Tsioufis, C., Selima, M., Tsiachris, D., Miliou, A., Kasiakogias, A., et al. (2009). Independent association of circulating resistin with glomerular filtration rate in the early stages of essential hypertension. J. Hum. Hypertens. 23, 668-673. doi: 10.1038/jhh.2009.12.
17. Dunbar, J. C., Hu, Y., and Lu, H. (1997). Intracerebroventricular leptin inreases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 46, 2040-2043. doi: 10.2337/diab.46.12.2040.
18. Elias, C. F., Lee, C., Kelly, J., Aschkenasi, C., Ahima, R. S., Couceyro, P. R., et al (1998). Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron 21, 1375-1385. doi: 10.1016/S0896-6273(00)80656-X.
19. Ellington, A. A., Malik, A. R., Klee, G. G., Turner, S. T., Rule, A. D., Mosley, T. H. Jr., et al. (2007). Association of plasma resistin with glomerular filtration rate and albuminuria in hypertensive adults. Hypertension 50, 708-714. doi: 10.1161/HYPERTENSIONAHA.107.095257.
20. Enriori, P. J., Sinnayah, P., Simonds, S. E., Garcia Rudaz, C., and Cowley, M. A. (2011). Leptin action in the dorsomedial hypothalamus increases sympathetic tone to brown adipose tissue in spite of systemic leptin resistance. J. Neurosci. 31, 12189-12197. doi: 10.1523/JNEUROSCI.2336-11.2011.
21. Esler, M., Straznicky, N., Eikelis, N., Masuo, K., Lambert, G., and Lambert, E. (2006). Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 48, 787-796. doi: 10.1161/01.HYP.0000242642.42177.49.
22. Furuhashi, M., Ura, N., Higashiura, K., Murakami, H., and Shimamoto, K. (2003). Circulating resistin levels in essential hypertension. Clin. Endocrinol. (Oxf.) 59, 507-510. doi: 10.1046/j.1365-2265.2003.01879.x.
23. Garrison, R. J., Kannel, W. B., Stokes, J. III., and Castelli, W. P. (1987). Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev. Med. 16, 235-251. doi: 10.1016/0091-7435(87)90087-9.
24. Ghosh, S., Singh, A. K., Aruna, B., Mukhopadhyay, S., and Ehtesham, N. Z. (2003). The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications. Gene 305, 27-34. doi: 10.1016/S0378-1119(02)01213-1.
25. Grassi, G., Colombo, M., Seravalle, G., Spaziani, D., and Mancia, G. (1998). Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension 31, 64-67. doi: 10.1161/01.HYP.31.1.64.
26. Gregor, M. F., and Hotamisligil, G. S. (2011). Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29, 415-445. doi: 10.1146/annurev-immunol-031210-101322.
27. Hall, J. E., Crook, E. D., Jones, D. W., Wofford, M. R., and Dubbert, P. M. (2002). Mechanisms of obesity-associated cardiovascular and renal disease. Am. J. Med. Sci. 324, 127-137. doi: 10.1097/00000441-200209000-00003.
28. Harlan, S. M., Guo, D.-F, Morgan, D. A., Fernandes-Santos, C., and Rahmouni, K. (2013). Hypothalamic mTORC1 signaling controls sympathetic nerve activity and arterial pressure and mediates leptin effects. Cell Metab. 17, 599-606. doi: 10.1016/j.cmet.2013.02.017.
29. Harlan, S. M., Morgan, D. A., Agassandian, K., Guo, D. F., Cassell, M. D., Sigmund, C. D., et al. (2011). Ablation of the leptin receptor in the hypothalamic arcuate nucleus abrogates leptin-induced sympathetic activation. Circ. Res. 108, 808-812. doi: 10.1161/CIRCRESAHA.111.240226.
30. Haynes, W. G., Morgan, D. A., Walsh, S. A., Mark, A. L., and Sivitz, W. I. (1997). Receptor mediated regional sympathetic nerve activation by leptin. J. Clin. Invest. 100, 270-278. doi: 10.1172/jci119532.
31. Hilzendeger, A. M., Morgan, D. A., Brooks, L., Dellsperger, D., Liu, X., Grobe, J. L., et al. (2012). A brain leptin-renin angiotensin system interaction in the regulation of sympathetic nerve activity. Am. J. Physiol. Heart Circ. Physiol. 303, H197-H206. doi: 10.1152/ajpheart.00974.2011.
32. Janke, J., Engeli, S., Gorzelniak, K., Luft, F. C., and Sharma, A. M. (2002). Resistin gene expression in human adipocytes is not related to insulin resistance. Obes. Res. 10, 1-5. doi: 10.1038/oby.2002.1.
33. Kassab, S., Kato, T., Wilkins, F. C., Chen, R., Hall, J. E., and Granger, J. P. (1995). Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 25, 893-897. doi: 10.1161/01.HYP.25.4.893.
34. Kosari, S., Camera, D. M., Hawley, J. A., Stebbing, M., and Badoer, E. (2013). ERK1/2 in the brain mediates the effects of central resistin on reducing thermogenesis in brown adipose tissue. Int. J. Physiol. Pathophysiol. Pharmacol. 5, 184-189.
35. Kosari, S., Rathner, J. A., and Badoer, E. (2012). Central resistin enhances renal sympathetic nerve activity via phosphatidylinositol 3-kinase but reduces the activity to brown adipose tissue via extracellular signal-regulated kinase 1/2. J. Neuroendocrinol. 24, 1432-1439. doi: 10.1111/j.1365-2826.2012.02352.x.
36. Kosari, S., Rathner, J. A., Chen, F., Kosari, S., and Badoer, E. (2011). Centrally administered resistin enhances sympathetic nerve activity to the hindlimb but attenuates the activity to brown adipose tissue. Endocrinology 152, 2626-2633. doi: 10.1210/en.2010-1492.
37. Lee, S., Lee, H.-C., Kwon, Y.-W., Lee, S. E., Cho, Y., Kim, J., et al. (2014). Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes. Cell Metabol. 19, 484-497. doi: 10.1016/j.cmet.2014.01.013.
38. Levin, B. E., Triscari, J., and Sullivan, A. C. (1983). Altered sympathetic activity during development of diet-induced obesity in rat. Am. J. Physiol. Integr. Regul. Physiol. 244, R347-R355.
39. Lieb, W., Sullivan, L. M., Harris, T. B., Roubenoff, R., Benjamin, E. J., Levy, D., et al. (2009). Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individuals. Diabetes Care 32, 612-616. doi: 10.2337/dc08-1596.
40. Lim, K., Burke, S. L., and Head, G. A. (2013). Obesity-related hypertension and the role of insulin and leptin in high-fat-fed rabbits. Hypertension 61, 628-634. doi: 10.1161/HYPERTENSIONAHA.111.00705.
41. Mark, A. L., Agassandian, K., Morgan, D. A., Liu, X., Cassell, M. D., and Rahmouni, K. (2009). Leptin signaling in the nucleus tractus solitarii increases sympathetic nerve activity to the kidney. Hypertension 53, 375-380. doi: 10.1161/HYPERTENSIONAHA.108.124255.
42. Mark, A. L., Correia, M. L., Rahmouni, K., and Haynes, W. G. (2002). Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J. Hypertens. 20, 1245-1250. doi: 10.1097/00004872-200207000-00001.
43. Mark, A. L., Shaffer, R. A., Correia, M. L., Morgan, D. A., Sigmund, C. D., and Haynes, W. G. (1999). Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J. Hypertens. 17, 1949-1953. doi: 10.1097/00004872-199917121-00026.
44. Mitchell, S. E., Nogueiras, R., Morris, A., Tovar, S., Grant, C., Cruickshank, M., et al. (2009). Leptin receptor gene expression and number in the brain are regulated by leptin level and nutritional status. J. Physiol. 587, 3573-3585. doi: 10.1113/jphysiol.2009.173328.
45. Montanaro, M. S., Allen, A. M., and Oldfield, B. J. (2005). Structural and functional evidence supporting a role for leptin in central neural pathways influencing blood pressure in rats. Exp. Physiol. 90, 689-696. doi: 10.1113/expphysiol.2005.030775.
46. Morash, B. A., Willkinson, D., Ur, E., and Wilkinson, M. (2002). Resistin expression and regulation in mouse pituitary. FEBS Lett. 526, 26-30. doi: 10.1016/S0014-5793(02)03108-3.
47. Morrison, S. F. (2004). Activation of 5-HT1A receptors in raphe pallidus inhibits leptin-evoked increases in brown adipose tissue thermogenesis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R832-R837. doi: 10.1152/ajpregu.00678.2003.
48. Nedergaard, J., Bengtsson, T., and Cannon, B. (2007). Unexpected evidence for active brown adipose tissue in adult humans. Am. J. Physiol. Endocrinol. Metab. 293, E444-E452. doi: 10.1152/ajpendo.00691.2006.
49. Ng, C. W., De Matteo, R., and Badoer, E. (2004). Effect of muscimol and L-NAME in the PVN on the RSNA response to volume expansion in conscious rabbits. Am. J. Physiol. Renal. Physiol. 287, F739-F746. doi: 10.1152/ajprenal.00431.2003.
50. Nohira, T., Nagao, K., Kameyama, K., Nakai, H., Fukumine, N., Okabe, K., et al. (2004). Identification of an alternative splicing transcript for the resistin gene and distribution of its mRNA in human tissue. Eur. J. Endocrinol. 151, 151-154. doi: 10.1530/eje.0.1510151.
51. Papadopoulos, D. P., Makris, T. K., Perrea, D., Papazachou, O., Daskalaki, M., Sanidas, E., et al. (2008). Adiponectin-insulin and resistin plasma levels in young healthy offspring of patients with essential hypertension. Blood Press 17, 50-54. doi: 10.1080/08037050701876307.
52. Papadopoulos, D. P., Perrea, D., Thomopoulos, C., Sanidas, E., Daskalaki, M., Papazachou, U., et al. (2009). Masked hypertension and atherogenesis: the impact on adiponectin and resistin plasma levels. J. Clin. Hypertens. (Greenwich) 11, 61-65. doi: 10.1111/j.1751-7176.2008.00070.x.
53. Patel, S. D., Rajala, M. W., Rossetti, L., Scherer, P. E., and Shapiro, L. (2004). Disulfide-dependent multimeric assembly of resistin family hormones. Science 304, 1154-1158. doi: 10.1126/science.1093466.
54. Piestrzeniewicz, K., Luczak, K., Komorowski, J., Maciejewski, M., Jankiewicz Wika, J., and Goch, J. H. (2008). Resistin increases with obesity and atherosclerotic risk factors in patients with myocardial infarction. Metabolism 57, 488-493. doi: 10.1016/j.metabol.2007.11.009.
55. Prior, L. J., Eikelis, N., Armitage, J. A., Davern, P. J., Burke, S. L., Montani, J. P., et al. (2010). Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 55, 862-868. doi: 10.1161/HYPERTENSIONAHA.109.141119.
56. Prior, L. J., Davern, P. J, Burke, S. L., Lim, K., Armitage, J. A., and Head, G. A. (2014). Exposure to a high-fat diet during development alters leptin and ghrelin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 63, 338-345. doi: 10.1161/HYPERTENSIONAHA.113.02498.
57. Rahmouni, K., Haynes, W. G., Morgan, D. A., and Mark, A. L. (2003). Intracellular mechanisms involved in leptin regulation of sympathetic outflow. Hypertension 41, 763-767. doi: 10.1161/01.HYP.0000048342.54392.40.
58. Rahmouni, K., and Morgan, D. A. (2007). Hypothalamic arcuate nucleus mediates the sympathetic and arterial pressure responses to leptin. Hypertension 49, 647-652. doi: 10.1161/01.HYP.0000254827.59792.b2.
59. Rahmouni, K., Morgan, D. A., Morgan, G. M., Mark, A. L., and Haynes, W. G. (2005). Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 54, 2012-2018. doi: 10.2337/diabetes.54.7.2012.
60. Rahmouni, K., Sigmund, C. D., Haynes, W. G., and Mark, A. L. (2009a). Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin. Diabetes 58, 536-542. doi: 10.2337/db08-0822.
61. Rahmouni, K., Sigmund, C. D., Haynes, W. G., and Mark, A. L. (2009b). Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin. Diabetes 58, 536-542. doi: 10.2337/db08-0822.
62. Rajala, M. W., Qi, Y., Patel, H. R., Takahashi, N., Banerjee, R., Pajvani, U. B., et al. (2004). Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 53, 1671-1679. doi: 10.2337/diabetes.53.7.1671.
63. Simonds, S. E., and Cowley, M. A. (2013). Hypertension in obesity: is leptin the culprit? Trends Neurosci. 36, 121-132. doi: 10.1016/j.tins.2013.01.004.
64. Simonds, S. E., Pryor, J. T., Ravussin, E., Greenway, F. L., Dileone, R., Allen, A. M., et al. (2014). Leptin mediates the increase in blood pressure associated with obesity. Cell 159, 1404-1416. doi: 10.1016/j.cell.2014.10.058.
65. Singhal, N. S., Lazar, M. A., and Ahima, R. S. (2007). Central resistin induces hepatic insulin resistance via neuropeptide Y. J. Neurosci. 27, 12924-12932. doi: 10.1523/JNEUROSCI.2443-07.2007.
66. Skibicka, K. P., and Grill, H. J. (2009). Hindbrain leptin stimulation induces anorexia and hyperthermia mediated by hindbrain melanocortin receptors. Endocrinology 150, 1705-1711. doi: 10.1210/en.2008-1316.
67. Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., et al. (2001). The hormone resistin links obesity to diabetes. Nature 409, 307-312. doi: 10.1038/35053000.
68. Steppan, C. M., and Lazar, M. A. (2002). Resistin and obesity-associated insulin resistance. Trends Endocrinol. Metab. 13, 18-23. doi: 10.1016/S1043-2760(01)00522-7.
69. Takata, Y., Osawa, H., Kurata, M., Kurokawa, M., Yamauchi, J., Ochi, M., et al. (2008). Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes. Hypertension 51, 534-539. doi: 10.1161/HYPERTENSIONAHA.107.103077.
70. Tanida, M., Hayata, A., Shintani, N., Yamamoto, N., Kurata, Y., Shibamoto, T., et al. (2013). Central PACAP mediates the sympathetic effects of leptin in a tissue-specific manner. Neuroscience 238, 297-304. doi: 10.1016/j.neuroscience.2013.02.016.
71. Tarkowski, A., Bjersing, J., Shestakov, A., and Bokarewa, M. I. (2010). Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J. Cell. Mol. Med. 14, 1419-1431. doi: 10.1111/j.1582-4934.2009.00899.x.
72. Thomopoulos, C., Daskalaki, M., Papazachou, O., Rodolakis, N., Bratsas, A., Papadopoulos, D. P., et al. (2010). Association of resistin and adiponectin with different clinical blood pressure phenotypes. J. Hum. Hypertens. 25, 38-46. doi: 10.1038/jhh.2010.22.
73. Thorp, A. A., and Schlaich, M. P. (2015). Relevance of sympathetic nervous system activation in obesity and metabolic syndrome. J. Diabetes Res. 2015:341583. doi: 10.1155/2015/341583.
74. Tovar, S., Nogueiras, R., Tung, L. Y., Castañeda, T. R., Vázquez, M. J., Morris, A., et al. (2005). Central administration of resistin promotes short-term satiety in rats. Eur. J. Endocrinol. 153, R1-R5. doi: 10.1530/eje.1.01999.
75. WHO (2014). Global Status Report on Noncommunicable Diseases 2014.
76. WHO (2015). Obesity and Overweight World Health Organisation (Fact sheet No 311) (updated January 2015).
77. Wilkinson, M., Wilkinson, D., Wiesner, G., Morash, B., and Ur, E. (2005). Hypothalamic resistin immunoreactivity is reduced by obesity in the mouse: co-localization with alpha-melanostimulating hormone. Neuroendocrinology 81, 19-30. doi: 10.1159/000084871.
78. Wofford, M. R., and Hall, J. E. (2004). Pathophysiology and treatment of obesity hypertension. Curr. Pharm. Des. 10, 3621-3637. doi: 10.2174/1381612043382855.
79. Xiong, X. Q., Chen, W. W., Han, Y., Zhou, Y. B., Zhang, F., Gao, X. Y., et al. (2012). Enhanced adipose afferent reflex contributes to sympathetic activation in diet-induced obesity hypertension. Hypertension 60, 1280-1286. doi: 10.1161/HYPERTENSIONAHA.112.198002.
80. Yang, R. Z., Huang, Q., Xu, A., McLenithan, J. C., Eisen, J. A., Shuldiner, A. R., et al. (2003). Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem. Biophys. Res. Commun. 310, 927-935. doi: 10.1016/j.bbrc.2003.09.093.
81. Young, C. N., Morgan, D. A., Butler, S. D., Mark, A. L., and Davisson, R. L. (2013). The brain subfornical organ mediates leptin-induced increases in renal sympathetic activity but not its metabolic effects. Hypertension 61, 737-744. doi: 10.1161/HYPERTENSIONAHA.111.00405.
82. Zhang, L., Curhan, G. C., and Forman, J. P. (2010). Plasma resistin levels associate with risk for hypertension among nondiabetic women. J. Am. Soc. Nephrol. 21, 1185-1191. doi: 10.1681/ASN.2009101053.
83. Zhang, L., Xiong, X. Q., Fan, Z. D., Gan, X. B., Gao, X. Y., and Zhu, G. Q. (2012). Involvement of enhanced cardiac sympathetic afferent reflex in sympathetic activation in early stage of diabetes. J. Appl. Physiol. (1985) 113, 47-55. doi: 10.1152/japplphysiol.01228.2011.
84. Zhang, Y., Kerman, I. A., Laque, A., Nguyen, P., Faouzi, M., Louis, G. W., et al. (2011). Leptin-receptor-expressing neurons in the dorsomedial hypothalamus and median preoptic area regulate sympathetic brown adipose tissue circuits. J. Neurosci. 31, 1873-1884. doi: 10.1523/JNEUROSCI.3223-10.2011.
85. Zhang, Y., Proenca, R., Maffei, M., Barone, M., and Leopold, L, Friedman, J. M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432. doi: 10.1038/372425a0.